EUVIMEDEUVIMED entdecken
Kohortenstudie

Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)

Nila J Dharan, Fengyi Jin, Stefanie Vaccher, Benjamin Bavinton, Barbara Yeung, Rebecca Guy, Andrew Carr, Iryna Zablotska, Janaki Amin, Philip Read, David J Templeton, Catriona Ooi und 9 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac660 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Nila J Dharan und 20 weiteren Autor:innen. Beteiligte Einrichtung: Kirby Institute, University of New South Wales Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: HIV Infections, HIV Seropositivity, Anti-HIV Agents, Sexual and Gender Minorities. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: New South Wales Ministry of Health and the Australian Capital Territory Health Directorate, Gilead Sciences Inc, Australian Government Research Training Program Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Most human immunodeficiency virus (HIV) seroconversions in people who have initiated preexposure prophylaxis (PrEP) occur in the context of insufficient adherence. We describe participants who seroconverted after being dispensed PrEP in a large PrEP implementation study in Australia.

Methods

Expanded PrEP Implementation in Communities in New South Wales was an implementation study of daily oral PrEP in individuals aged ≥18 years at high risk for acquiring HIV. HIV seroconversions were defined as a positive HIV test by either antigen, antibody, or detectable HIV viral load after enrollment. Insufficient adherence, measured by dispensing logs or participant self-report, was defined as <4 PrEP doses per week.

Results

A total of 9596 participants were enrolled and dispensed PrEP between 1 March 2016 and 30 April 2018; 30 were diagnosed with HIV by 31 March 2019. The median (interquartile range [IQR]) age was 31 (25–38) years, all identified as male, 29 (97%) identified as gay or homosexual, and 20 (69%) lived in a postcode with a low concentration of gay male residents. The median (IQR) days from first PrEP dispensing to diagnosis was 409 (347–656). There was no evidence that participants who seroconverted had been sufficiently adherent to PrEP. Nineteen (63%) participants who seroconverted were diagnosed with chlamydia, gonorrhoea, syphilis, or new hepatitis C infection. One participant had resistance to emtricitabine (M184V mutation) at diagnosis.

Conclusions

Participants who seroconverted were insufficiently adherent to PrEP despite being at high risk for acquiring HIV. Understanding the reasons for poor PrEP adherence in individuals who subsequently acquire HIV is critical to improving PrEP effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV SeropositivityAnti-HIV AgentsSexual and Gender MinoritiesPre-Exposure ProphylaxisHumansMaleAdolescentAdultHomosexuality, MaleHIVProspective StudiesCohort StudiesSeroconversionMedication Adherence

Stichwörter der Autor:innen

HIV risk behaviorsHIV seroconversionPrEPadherence

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Kirby Institute, University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
  • University of New South Wales Sydney, Sydney, New South Wales, Australia.
  • Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Westmead, New South Wales, Australia.
  • Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Westmead, New South Wales, Australia.
  • Western Sydney Sexual Health Centre, Western Sydney Local Health District, Parramatta, New South Wales, Australia.

Förderung

  • New South Wales Ministry of Health and the Australian Capital Territory Health Directorate
  • Gilead Sciences Inc
  • Australian Government Research Training Program Scholarship
  • Centre for Population Health, NSW Ministry of Health
  • Health Ministry New South Wales

Zitieren

APA

Dharan, N. J., Jin, F., Vaccher, S., Bavinton, B., Yeung, B., Guy, R., Carr, A., Zablotska, I., Amin, J., Read, P., Templeton, D. J., Ooi, C., Martin, S. J., Ryder, N., Smith, D. E., McNulty, A., Brown, K., Price, K., Holden, J., …, & Expanded PrEP Implementation in Communities in New South Wales (EPIC-NSW) research group (2023). Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW). Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac660

Vancouver

Dharan NJ, Jin F, Vaccher S, Bavinton B, Yeung B, Guy R, et al. Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW). Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac660

BibTeX
@article{Dharan2023,
  author = {Dharan, Nila J and Jin, Fengyi and Vaccher, Stefanie and Bavinton, Benjamin and Yeung, Barbara and Guy, Rebecca and Carr, Andrew and Zablotska, Iryna and Amin, Janaki and Read, Philip and Templeton, David J and Ooi, Catriona and Martin, Sarah J and Ryder, Nathan and Smith, Don E and McNulty, Anna and Brown, Katherine and Price, Karen and Holden, Jo and Grulich, Andrew E and Expanded PrEP Implementation in Communities in New South Wales (EPIC-NSW) research group, Expanded PrEP Implementation in Communities in New South Wales (EPIC-NSW) research group},
  title = {Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac660}
}
Kostenlos starten →